136 related articles for article (PubMed ID: 28203521)
1. Down-regulation of miR-26b induces cisplatin resistance in nasopharyngeal carcinoma by repressing JAG1.
Shi L; Yin W; Zhang Z; Shi G
FEBS Open Bio; 2016 Dec; 6(12):1211-1219. PubMed ID: 28203521
[TBL] [Abstract][Full Text] [Related]
2. miR-26b-5p suppresses proliferation and promotes apoptosis in multiple myeloma cells by targeting JAG1.
Jia CM; Tian YY; Quan LN; Jiang L; Liu AC
Pathol Res Pract; 2018 Sep; 214(9):1388-1394. PubMed ID: 30098829
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-26b acts as an antioncogene and prognostic factor in cervical cancer.
Wang L; Wang W; Wu Y
Oncol Lett; 2019 Mar; 17(3):3418-3424. PubMed ID: 30867779
[TBL] [Abstract][Full Text] [Related]
4. Effect of miR-26b-5p on cis-diamine dichloroplatinum-induced ovarian granulosa cell injury by targeting MAP3K9.
Liu S; Li L; Li M; Zhang J
In Vitro Cell Dev Biol Anim; 2020 Mar; 56(3):213-221. PubMed ID: 32185607
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-101-3p advances cisplatin sensitivity in bladder urothelial carcinoma through targeted silencing EZH2.
Li B; Xie D; Zhang H
J Cancer; 2019; 10(12):2628-2634. PubMed ID: 31258770
[No Abstract] [Full Text] [Related]
6. HOXA11-AS induces cisplatin resistance by modulating the microRNA-98/PBX3 axis in nasopharyngeal carcinoma.
Li H; Huang J; Yu S; Li H; Zhou Y; Wu Q
Oncol Lett; 2021 Jun; 21(6):493. PubMed ID: 33968209
[TBL] [Abstract][Full Text] [Related]
7. Comparative Proteomic Profiling of Cisplatin-resistant Nasopharyngeal Carcinoma Cell Lines: Novel Biomarkers for Improving Chemotherapy of NPC.
Prathaphan P; Reamtong O; Ngaokrajang U; Janvilisri T; Swainson NM; Kiatwuthinon P
Anticancer Res; 2022 Jul; 42(7):3507-3522. PubMed ID: 35790268
[TBL] [Abstract][Full Text] [Related]
8. miRNA-181a-5p Enhances the Sensitivity of Cells to Cisplatin in Esophageal Adenocarcinoma by Targeting CBLB.
Yang S; Wang P; Wang S; Cong A; Zhang Q; Shen W; Li X; Zhang W; Han G
Cancer Manag Res; 2020; 12():4981-4990. PubMed ID: 32612385
[TBL] [Abstract][Full Text] [Related]
9. MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells.
John Clotaire DZ; Zhang B; Wei N; Gao R; Zhao F; Wang Y; Lei M; Huang W
Biochem Biophys Res Commun; 2016 Mar; 472(1):194-200. PubMed ID: 26920049
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-140 inhibits tumor progression in nasopharyngeal carcinoma by targeting CXCR4.
Yao C; Huang S; Wu J; Yin L; Jiang X; Chen C; Wu W; Xu J; He X
Int J Clin Exp Pathol; 2017; 10(7):7750-7759. PubMed ID: 31966622
[TBL] [Abstract][Full Text] [Related]
11. Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin.
Zang S; Zhao S; Gao X; Li Y; Zhong C; Gao J
Onco Targets Ther; 2019; 12():7551-7560. PubMed ID: 31686855
[TBL] [Abstract][Full Text] [Related]
12. MiR-26b inhibits melanoma cell proliferation and enhances apoptosis by suppressing TRAF5-mediated MAPK activation.
Li M; Long C; Yang G; Luo Y; Du H
Biochem Biophys Res Commun; 2016 Mar; 471(3):361-7. PubMed ID: 26872428
[TBL] [Abstract][Full Text] [Related]
13. MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2.
Li H; Sun Q; Han B; Yu X; Hu B; Hu S
Int J Clin Exp Pathol; 2015; 8(5):4782-90. PubMed ID: 26191168
[TBL] [Abstract][Full Text] [Related]
14. Mcl-1 Is a Novel Target of miR-26b That Is Associated with the Apoptosis Induced by TRAIL in HCC Cells.
Jiang C; Long J; Liu B; Xie X; Kuang M
Biomed Res Int; 2015; 2015():572738. PubMed ID: 26078955
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-26b inhibits osteosarcoma cell migration and invasion by down-regulating PFKFB3 expression.
Zheng WD; Zhou FL; Lin N
Genet Mol Res; 2015 Dec; 14(4):16872-9. PubMed ID: 26681033
[TBL] [Abstract][Full Text] [Related]
16. Systemic Bcl-2 antisense oligodeoxynucleotide in combination with cisplatin cures EBV+ nasopharyngeal carcinoma xenografts in SCID mice.
Lacy J; Loomis R; Grill S; Srimatkandada P; Carbone R; Cheng YC
Int J Cancer; 2006 Jul; 119(2):309-16. PubMed ID: 16477627
[TBL] [Abstract][Full Text] [Related]
17. Kaempferol Inhibits Hepatic Stellate Cell Activation by Regulating miR-26b-5p/Jag1 Axis and Notch Pathway.
Zhou G; Li C; Zhang R; Zhan Y; Lin L; Lang Z; Tao Q; Zheng J
Front Pharmacol; 2022; 13():881855. PubMed ID: 35721153
[TBL] [Abstract][Full Text] [Related]
18. Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b.
Zhuang Q; Zhou T; He C; Zhang S; Qiu Y; Luo B; Zhao R; Liu H; Lin Y; Lin Z
J Exp Clin Cancer Res; 2016 Apr; 35():67. PubMed ID: 27074866
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-26b regulates the expression of cyclooxygenase-2 in desferrioxamine-treated CNE cells.
Ji Y; He Y; Liu L; Chong X
FEBS Lett; 2010 Mar; 584(5):961-7. PubMed ID: 20100477
[TBL] [Abstract][Full Text] [Related]
20. MiR-26b modulates insulin sensitivity in adipocytes by interrupting the PTEN/PI3K/AKT pathway.
Xu G; Ji C; Song G; Zhao C; Shi C; Song L; Chen L; Yang L; Huang F; Pang L; Zhang N; Zhao Y; Guo X
Int J Obes (Lond); 2015 Oct; 39(10):1523-30. PubMed ID: 25999046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
